# Cytokinetics Inc. (CYTK)

Cytokinetics Inc. (CYTK) stock surges to a 52-week high following FDA approval of Myqorzo, despite some market concerns.

### About Cytokinetics Inc.
Cytokinetics Inc. is a biopharmaceutical company focused on the development of muscle activators.  
Cytokinetics Inc. uses the ticker $CYTK for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Cytokinetics Inc. (CYTK) trading volume is up 17.09% from the previous week.
- Cytokinetics Inc. (CYTK) social dominance is up 57.91% from the previous week.
- Cytokinetics Inc. (CYTK) Galaxy Score™ is up 96% from the previous month.
- Cytokinetics Inc. (CYTK) posts created is up 60% from the previous week.

### Price: $66.30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/close.tsv)  
The stock price has surged to a 52-week high, driven by the FDA approval of Myqorzo and positive analyst sentiment, despite some valuation concerns and general market negativity.  

24-Hour: 1.88%
7-Day: 6.68%
30-Day: 5.88%

1-Year High: $68.20 on 2025-11-26  
1-Year Low: $29.80 on 2025-05-15  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/alt_rank.tsv)  
Cytokinetics Inc. (CYTK) is currently AltRank #1,371 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +109  
[--] Month: [-----] +557  
[--] Months: [-----] +735  
[--] Year: [-----] +1,246  
1-Year High: [-----] on 2025-06-29  
1-Year Low: [--] on 2025-09-02  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +5  
[--] Month: [--] +24  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-04-24  
1-Year Low: [--] on 2025-08-01  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] -55%  
[--] Month: [-------] -77%  
[--] Months: [---------] +70%  
[--] Year: [---------] +9%  
1-Year High: [-------] on 2025-09-02  
1-Year Low: [---] on 2026-02-08  

Engagements by network (24h):
News: [-----]
YouTube: [--]
Reddit: [--]
X: [-----]
TikTok: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] -55%  
[--] Month: [-----] +4.60%  
[--] Months: [-----] +47%  
[--] Year: [-----] +3.60%  
1-Year High: [---] on 2025-09-03  
1-Year Low: [--] on 2025-06-13  

Mentions by network (24h):
News: [--]
YouTube: [--]
Reddit: [--]
X: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Cytokinetics Inc. (CYTK) in the last [--] hours which is down 1.50% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -47%  
[--] Month: [---] +7.10%  
[--] Months: [-----] +0.60%  
[--] Year: [-----] +76%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-05-24  

The most influential creators that mention Cytokinetics Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@TOWiU2](/creator/twitter/TOWiU2)                   | [--]    | [-----]     | [--]     | [---]         |
| [@WolfOfPathogens](/creator/twitter/WolfOfPathogens) | [--]    | [--]         | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [-----]     | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | [--]    | [------]    | [--]     | [--]          |
| [@Rakufl47519](/creator/twitter/Rakufl47519)         | [--]    | [--]         | [--]     | [--]          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@Bigg0698830](/creator/twitter/Bigg0698830)         | [--]    | [--]        | [--]     | [--]          |
| [@Signal_Trader01](/creator/twitter/Signal_Trader01) | [--]    | [--]        | [--]     | [--]           |
| [@BiotechTV](/creator/twitter/BiotechTV)             | [--]   | [------]    | [--]     | [--]           |

[View More](/list/creators/$cytk/100)
  
  
### Sentiment: 56%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/sentiment.tsv)  
Current Value: 56%  
Daily Average: 73%  
[--] Week: 50% -50%  
[--] Month: 50% -10%  
[--] Months: 50% -32%  
[--] Year: 50% -1%  
1-Year High: 100% on 2025-04-22  
1-Year Low: 26% on 2025-12-07  

Most Supportive Themes:
- FDA Approval of Myqorzo: (70%) Cytokinetics' aficamten (Myqorzo) has received FDA approval for symptomatic obstructive hypertrophic cardiomyopathy (oHCM), marking a significant milestone for the company.
- Myqorzo's Differentiated Profile: (20%) Market analysis suggests Myqorzo's label and REMS program are differentiated from competitors like Camzyos, potentially offering advantages in administration and monitoring.
- Positive Analyst Sentiment and Price Targets: (10%) Analysts have reiterated outperform ratings and increased price targets for CYTK, citing the FDA approval and Myqorzo's strong market potential.
  
Most Critical Themes:
- General Market Sentiment: (50%) Despite positive company-specific developments, general negative market sentiment is currently influencing commentary about Cytokinetics Inc. (CYTK).
- Competition from Camzyos: (30%) While Myqorzo shows promise, it faces competition from an entrenched competitor, Camzyos, and its market adoption will be closely watched.
- Valuation Concerns: (20%) Some users express difficulty in justifying the current valuation for CYTK, despite the positive news, indicating potential overvaluation concerns.
  
  
  
### Social Dominance: 0.00592%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/social_dominance.tsv)  
Current Value: 0.00592%  
Daily Average: 0.018%  
[--] Week: 0.00679% +0.00249%  
[--] Month: 0.0076% -0.005%  
[--] Months: 0.0076% -0.0015%  
[--] Year: 0.0076% -0.032%  
1-Year High: 0.079% on 2025-09-03  
1-Year Low: 0.0059% on 2025-10-24  
  
  
### Market Dominance: 0.00917%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/market_dominance.tsv)  
Current Value: 0.00917%  
Daily Average: 0%  
1-Year High: 0.021% on 2025-03-31  
1-Year Low: 0.00491% on 2025-05-15  
  
  
### Market Cap: $8,101,274,196
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/market_cap.tsv)  
Current Value: $8,101,274,196  
Daily Average: $5,800,865,391  
[--] Week: $8,101,274,196 +8.60%  
[--] Month: $8,101,274,196 +4.50%  
[--] Months: $8,101,274,196 +74%  
[--] Year: $8,101,274,196 +49%  
1-Year High: $8,332,354,911 on 2025-11-26  
1-Year Low: $3,563,710,423 on 2025-05-15  

### Top Cytokinetics Inc. News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"Top 2% Biotech Hits Slam Dunk On Bid To Edge Out Bristol Cytokinetics Edgewise Therapeutics is trying to edge into a market already owned by Bristol Myers Squibb just behind Cytokinetics"  
[News Link](https://www.investors.com/news/technology/edgewise-therapeutics-obstructive-hypertrophic-cardiomyopathy/) [@dbielecki21](/creator/x/dbielecki21) 2024-09-19T13:44Z 208.1M followers, [----] engagements



### Top Cytokinetics Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@LTbioinvestor $VKTX $SRPT $CYTK $IDYA Week [--] after Poll:"  
[X Link](https://x.com/TOWiU2/status/2022432922314375625) [@TOWiU2](/creator/x/TOWiU2) 2026-02-13T22:09Z [----] followers, [---] engagements


"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona Lasofoxifene Fulvestrant ($1.2B annual) 87% Instit huge time arbtitrage oppor"  
[X Link](https://x.com/WolfOfPathogens/status/2022327290168782905) [@WolfOfPathogens](/creator/x/WolfOfPathogens) 2026-02-13T15:09Z [--] followers, [---] engagements


"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona lona 87% instit ownership/ Perceptive Tang capital $6.35m insider buy at $6.00 New phase [--] oncology asset"  
[X Link](https://x.com/WolfOfPathogens/status/2022028325682548910) [@WolfOfPathogens](/creator/x/WolfOfPathogens) 2026-02-12T19:21Z [--] followers, [---] engagements


"LT position into [----] Part [--] # [--] Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions in order- $AMZN $TSLA $SOFI $COIN $GOOG $NVDA $AMD $RBRK $META $NFLX $UBER $MSFT $AVGO $ZS $MELI $IREN $NBIS Top Biotech positions: $VKTX $CYTK $BBIO $TMDX $MDGL $HROW $SLNO $IMNM $GPCR $OCUL $CRVS https://twitter.com/i/web/status/2002067407834374356 https://twitter.com/i/web/status/2002067407834374356"  
[X Link](https://x.com/Pharmdca/status/2002067407834374356) [@Pharmdca](/creator/x/Pharmdca) 2025-12-19T17:24Z 108.6K followers, 56.1K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing